Regulation of haematopoiesis by growth factors - Emerging insights and therapies

Expert Opinion on Biological Therapy

Volumn 4, Issue 6, 2004, Pages 869-879

  Thomas, Daniel ^a   Vadas, Mathew ^a   Lopez, Angel ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

GM CSF; Instructive haematopoiesis; M CSF; SCF; Stem cell

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; COLONY STIMULATING FACTOR 1; EPHRIN B2; ERYTHROPOIETIN; FIBROBLAST GROWTH FACTOR; FLT3 LIGAND; FRIZZLED PROTEIN; GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR RECEPTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 11; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 5; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; NERVE CELL ADHESION MOLECULE; NOTCH RECEPTOR; PHOSPHOTYROSINE; SMAD PROTEIN; SOMATOMEDIN C; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1; THROMBOPOIETIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNINDEXED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANEMIA; APLASTIC ANEMIA; ASTHMA; ATOPY; AUTOIMMUNE DISEASE; BIOLOGICAL THERAPY; BONE MARROW CELL; BONE METABOLISM; CELL DIFFERENTIATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNITY; KNOCKOUT MOUSE; MACROPHAGE; MUCOSA INFLAMMATION; MYELODYSPLASIA; NEUTROPENIA; NONHUMAN; OLIGOMERIZATION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTOPENIA;

ANIMALS; BONE MARROW CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GROWTH SUBSTANCES; HEMATOPOIESIS; HEMATOPOIETIC CELL GROWTH FACTORS; HUMANS; INTERLEUKIN-3; LEUKEMIA; LUNG DISEASES; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MICE, KNOCKOUT; PEPTIDES; STEM CELL FACTOR; STEM CELLS; THROMBOPOIETIN;

EID: 3042645271     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.4.6.869     Document Type: Review

References (91)

1. FUCHS E, SEGRE JA: Stem cells a new lease on life. Cell (2000) 100:143-155.
2. ZHU J, EMERSON S: Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene (2002) 21:3295-3313.
3. OSAWA M, HANADA K, HAMADA H, NAKAUCHI H: Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science (1996) 273:242-245.
4. BJORNSON CR, RIETZE RL, REYNOLDS BA, MAGLI MC, VESCOVI AL: Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science (1999) 283:534-537.
5. BRAZELTON TR, ROSSI FM, KESHET GI, BLAU HM: From marrow to brain: expression of neuronal phenotypes in adult mice. (2000) Science 290:1775-1779.
6. IVANOVA NB, DIMOS JT, SCHANIEL C et al.: A stem cell molecular signature. Science (2002) 298:601-604.
7. OGAWA M: Differentiation and proliferation of hematopoietic stem cells. Blood (1993) 81:2844-2853.
8. LEMISCHKA IR. Microenvironmental regulation of hematopoieic stem cells. Stem Cells (1997) 15(Suppl. 1):63-69.
9. MONTECINO-RODRIGUEZ E, DORSHKIND K: Regulation of hematopoiesis by gap junction-mediated intercellular communication. J. Leukoc. Biol. (2001) 70:341-347.
10. HESISSIG B, HATTORI K, DIAS S et al: Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-Ligand. Cell (2002) 109:625-637.
11. T/CXCL2delta4. Blood (2004) 103:110-119.
12. KARANU FN, MURDOCH B, GALLACHER L et al.: The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. J. Exp. Med. (2000) 192:1365-1372.
13. BIGAS A, MARTIN DIK, MILNER LA: Notch1 and Notch2 inhibit myeloid differentiation in response to different cytokines. Mol. Cell. Biol. (1998) 18:2324-2333.
14. LAM LT, RONCHINI C, NORTON J et al.: Suppression of erythroid but not megakaryocytic differentiation of human K562 erythroleukemic cells by notch-1. J. Biol. Chem. (2000) 275:19676-19684.
15. KRAUSE DS: Regulation of hematopoietic stem cell fate. Oncogene (2002) 21:3262-3269.
16. BIGAS A, MILNER LA: Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. Blood (1999) 93:2431-2448.
17. INGLES-ESTEVE J, ESPINOSA L, MILNER LA, CAELLES C, BIHAS A: Phosphorylation of Ser2078 modulates the Notch2 function in 32D cell differentiation. J. Biol. Cbem. (2001) 276:44873-44880.
18. CALVI LM, ADAMS GB, WELBRECHT KW et al.: Osteoblastic cells regulate the haematopoietic stem cell niche. Nature (2003) 425:841-846.
19. MARTIN C, BRUDON PC, BRIDGER G et al: Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity (2003) 19:583-593.
20. LEVESQUE JP, HENDY J, TAKAMATSU Y et al: Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCS or cyclophosphamide. J. Clin. Invest. (2003) 111:187-196.
21. SEMERAD CL, LIU F, GREGORY AD et al: G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood. Immunity (2002) 17:413-423.
22. PELUS LM, BIAN H, KING AG, FUKUDA S: Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GROβ/CXCL2 and GROβT/ CXCL2Δ4. Blood (2004) 103(1):110-119.
23. LEVESQUE JP, HENDY J, WINKLER IG et al.: Granulocyte colony-stimulating factor induces the release in the bone marrow of proteases that cleave c-KIT receptor (CD117) from the surface of hematopoietic progenitor cells. Exp. Hematol. (2003) 31:109-117.
24. LEVESQUE JP, HENDY J, TAKAMATSU Y et al.: Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. Exp. Hematol. (2002) 30:440-449.
25. LI MO, SARKISIAN MR, MEHAL WZ, RAKIC P, FLAVELL RA: Phosphatidylserine receptor is required for clearance of apoptotic cells. Science (2003) 302:1560-1563.
26. ROVERE P, PERI G, FAZZINI F et al: The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. Blood (2000) 96:4300-4306.
27. BURNS AR, BOWDEN RA, MACDONELL SD et al.: Analysis of tight junctions during neutrophil transendothelial migration. J. Cell Sci. (2000) 113:45-57.
28. BURNS AR, WALKER DC, BROWN ES et al.: Neutrophil transendothelial migration is independent of tight junctions and occurs preferentially at tricellular corners. J. Immunol. (1997) 159:2893-2903.
29. STEIN BN, GAMBLE JR, PITSON SM, VADAS MA, KHEW-GOODALL Y: Activation of endothelial extracellular signal-regulated kinase is essential for neutrophil transmigration: potential involvement of a soluble neutrophil factor in endothelial activation. J. Immunol. (2003) 171(11):6097-6104.
30. YAMAMOTO H, SEDGWICK JB, VRTIS RF, BUSSE WW: The effect of transendothelial migration on eosinophil function. Am. J. Respir. Cell Mol. Biol. (2000) 23:379-388.
31. MULLER WA, RANDOLPH GJ: Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes. J. Leukoc. Biol. (1999) 66:698-704.
32. OTTONELLO L, CUTOLO M, FRUMENTO G et al.: Synovial fluid from patients with rheumatoid arthritis inhibits neutrophil apoptosis: role of adenosine and proinflammatory cytokines. Rheumatology (Oxford) (2002) 41:1249-1260.
33. GUTHRIDGE MA, STOMSKI FC, THOMAS D et al.: Mechanism of activation of the GM-CSF, IL-3, and IL-5 family of receptors. Stem Cells (1998) 16:301-313.
34. LOTEM J, SACHS L: Cytokine control of developmental programs in normal hematopoiesis and leukemia. Oncogene (2002) 21:3284-3294.
35. HAMILTON JA: GM-CSF in inflammation and autoimmunity. Trends Immunol. (2002) 23:403-408.
36. VAN LEEUWEN BH, MARTINSON ME, WEBB GC, YOUNG IG: Molecular organization of the cytokine gene cluster, involving the human IL-3, IL-4, IL-5, and GM-CSF genes, on human chromosome 5. Blood (1989) 73:1142-1148.
37. OGAWA M: Differentiation and proliferation of hematopoietic stem cells. Blood (1993) 81:2844-2853.
38. BROUDY VC: Stem cell factor and hematopoiesis. Blood (1997) 90:1345-1364.
39. RYFFEL B, MIHATSCH MJ, WOERLY G: Pathology induced by interleukin-6. Int. Rev. Exp. Pathol. (1993) 34:79-89.
40. ISHIBASHI T, KIMURA H, UCHIDA T et al.: Human interleukin 6 is a direct promoter for maturation of megakaryocytes in vitro. Proc. Natl. Acad. Sci. USA (1989) 86:5953-5957.
41. ROBB L, DRINKWATER CC, METCALF D et al.: Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. Proc. Natl. Acad. Sci. USA (1995) 92:9565-9569.
42. SCHEDING S, BERGMANN M, SHIMOSAKA A, WOLFF P et al.: Human plasma thrombopoietin levels are regulated by binding to platelet thrombopoietin receptors in vivo. Transfusion (2002) 42:321-328.
43. SMITH MA, COURT EL, SMITH JG: Stem cell factor: laboratory and clinical aspects. Blood Rev. (2001) 15:191-197.
44. MIYAZAWA K, WILLIAMS DA, GOTOH A, NISHIMAKI J, BROXMEYER HE, TOYAMA K: Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form. Blood (1995) 85:641-649.
45. SLATER NJ, YAMAGUCHI M, ROTHWELL DG, BAKER P, HEYWORTH CM, CHOPRA R: The human granulocyte/macrophage colony-stimulating factor receptor alpha2 isoform influences haemopoietic lineage commitment and divergence. Br. J. Haematol. (2003) 122:150-158.
46. GALE RE, FREEBURN RW, KHWAJA A, CHOPRA R, LINCH DC: A truncated isoform of the human beta chain common to the receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3), and IL-5 with increased mRNA expression in some patients with acute leukemia. Blood (1998) 91:54-63.
47. HEANEY ML, VERA JC, RAINES MA, GOLDE DW: Membrane-associated and soluble granulocyte/macrophage-colony-stimulating factor receptor alpha subunits are independently regulated in HL-60 cells. Proc. Natl. Acad. Sci. USA (1995) 92:2365-2369.
48. YANG FC, WATANABE S, TSUJI K et al.: Human granulocyte colony-stimulating factor (G-CSF) stimulates the in vitro and in vivo development but not commitment of primitive multipotential progenitors from transgenic mice expressing the human G-CSF receptor. Blood (1998) 92:4632-4640.
49. LAGASSE E, WEISSMAN IL: Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell. (1997) 89:1021-1031.
50. KONDO M, SCHERER DC, MIYAMOTO T et al.: Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature (2000) 407:383-386.
51. IWASAKI-ARAI J, IWASAKI H, MIYAMOTO T, WATANABE S, AKASHI K: Enforced granulocyte/macrophage colony stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion. J. Exp. Med. (2003) 10:1311-1322.
52. EVANS CA, PIERCE A, WINTER S et al.: Activation of granulocyte-macrophage colony-stimulating factor and interlekin-3 receptor subunits in a multipotential hematopoietic progenitor cell line leads to differential effects on development. Blood (1999) 94:1504-1514.
53. EVANS CA, ARIFFIN S, PIERCE A. WHETTON AD: Identification of primary structural features that define the differential actions of IL-3 and GM-CSF receptors. Blood (2002) 100:3164-3174.
54. SCHMID I, BALDWIN GC, JACOBS EL et al.: Alterations in phenotype and cell-surface antigen expression levels of human monocytes: differential response to in vivo administration of rhM-CSF or rhGM-CSF. Cytometry (1995) 22:103-110.
55. CHAPUIS F, ROSENZWAJG M, YAGELLO M, EKMAN M, BIBERFELD P, GLUCKMAN JC: Differentiation of human dendritic cells from monocytes in vitro. Eur. J. Immunol. (1997) 27:431-441.
56. STANLEY E, LIESCHKE GJ, GRAIL D et al.: Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbartion of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl. Acad. Sci. USA (1994) 91:5592-5596.
57. SHIBATA Y, BERCLAZ PY, CHRONEOS ZC, YOSHIDA M, WHITSETT JA, TRAPNELL BC: GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU. 1. Immunity (2001) 15:557-567.
58. ENZLER T, GILLESSEN S, MANIS JP et al.: Deficiencies of GM-CSF and interferon gamma link inflammation and cancer. J. Exp. Med. (2003) 197:1213-1219.
59. METCALF D, NICOLA NA, GOUGH NM, ELLIOTT M, MCARTHUR G, LI M: Synergistic suppression: anomalous inhibition of the proliferation of factor-dependent hemopoietic cells by combination of two colony-stimulating factors. Proc. Natl. Acad. Sci. USA (1992) 89:2819-2823.
60. GEISSMANN F, JUNG S, LITTMAN DR: Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity (2003) 19:71-82.
61. FORTUNEL NO, HATZFELD JA, MONIER MN, HATZFELD A. Control of hematopoietic stem/progenitor cell fate by transforming growth factor-beta. Oncol. Res. (2003) 13:445-453.
62. LE Y, MURPHY PM, WANG JM: Formyl-peptide receptors revisited. Trends Immunol. (2002) 23:541-548.
63. SUENOBU S, TAKAKURA N, INADA T et al.: A role of EphB4 receptor and its ligand, ephrin-B2, in erythropoiesis. Biochem. Biophys. Res. Commun. (2002) 293:1124-1131.
64. DEMIROGLU H: Postrenal transplant erythrocytosis: the roles of testosterone and erythropoietin. Clin. Nephrol. (1997) 47:279.
65. SCHLESSINGER J: Cell signalling by receptor tyrosine kinases. Cell (2000) 103:211-225.
66. HERCUS TR, BAGLEY CJ, CAMBARERI B et al.: Specific human granulocyte-macrophage colony-stimulating factor antagonists. Proc. Natl. Acad. Sci. USA (1994) 91:5838-5842.
67. MCCLURE BJ, HERCUS TR, CAMBARERI BA et al.: Molecular assembly of the ternary granulocyte-macrophage colony-stimulating factor receptor complex. Blood (2003) 101:1308-1315.
68. SPORENO E, SAVINO R, CIAPPONI L et al.: Human interleukin-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells. Blood (1996) 87:4510-4519.
69. BOULANGER MJ, CHOW DC, BREVNOVA EE, GARCIA KC: Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex. Science (2003) 300:2101-2104.
70. KORPELAINEN EI, GAMBLE JR, VADAS MA, LOPEZ AF: IL-3 receptor expression, regulation and function in cells of the vasculature. Immunol. Cell Biol. (1996) 74:1-7.
71. STOMSKI FC, DOTTORE M, WINNALL W et al.: Identification of a 14-3-3 binding sequence in the common beta chain of the granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and IL-5 receptors that is serine-phosphorylated by GM-CSF. Blood (1999) 94(6):1933-1942.
72. GUTHRIDGE MA, STOMSKI FC, BARRY EF et al.: Site-specific serine phosphorylation of the IL-3 receptor is required for hemopoietic cell survival. Mol. Cell (2000) 6:99-108.
73. VAUDRY D, STORK PJ, LAZAROVICI P, EIDEN LE: Signaling pathways for PC12 cell differentiation: making the right connections. Science (2002) 296:1648-1649.
74. METCALF D, BEGLEY CG, JOHNSON GR et al.: Biologic properties in vitro of a recombinant human granulocyte-macrophage colony-stimulating factor. Blood (1986) 67:37-45.
75. NEMUNAITIS J, SHANNON-DORCY K, APPELBAUM FR et al.: Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor. Blood (1993) 82:1422-1427.
76. BLAISE D, FAUCHER C, VEY N, CARAUX J, MARACHINI D, CHABANNON C: Rescue of haematopoiesis by a combination of growth factors including stem cell factor. Lancet (2000) 356:1325-1326.
77. CANTOR SB, ELTING LS, HUDSON DV JR, RUBENSTEIN EB: Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy. Cancer (2003) 97:3099-3106.
78. ELLIS M, ZWAAN F, HEDSTROM U et al.: Recombinant human interleukin 11 and bacterial infection in patients with correction of haematological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial. Lancet (2003) 361:275-280.
79. BASSER RL, RASKO JE, CLARKE K et al.: Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer. Lancet (1996) 348:1279-1281.
80. KUTER DJ, BEGLEY CG: Recombinant human thrombopoietin: basic biology and evaluation of clinical studies. Blood (2002) 100:3457-3469.
81. JOHNSON DL, FARRELL FX, BARBONE FP et al.: Identification of a 13 amino acid peptide mimetic of erythropoietin and description of amino acids critical for the mimetic activity of EMP1. Biochemistry (1998) 37:3699-3710.
82. TIAN SS, LAMB P, KING AG et al.: A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor. Science (1998) 281:257-259.
83. KUSANO K, EBARA S, TACHIBANA K et al.: Potential therapeutic role for small nonpeptidyl compounds that mimic human granulocyte colony-stimulating factor. Blood (2004) 103(3):836-842.
84. PETRUCCI M, RICCIARDI MR, GREGORJ C et al.: Effects of IL-6 variants in multiple myeloma: growth inhibition and induction of apoptosis in primary cells. Leuk. Lymphoma (2002) 43:2369-2375.
85. COOK AD, BRAINE EL, CAMPBELL IK, RICH MJ, HAMILTON JA: Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease. Arthritis Res. (2001) 3:293-298.
86. KITCHING AR, RU HUANG X, TURNER AL, TIPPING PG, DUNN AR, HOLDSWORTH SR: The requirement for granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in leukocyte-mediated immune glomerular injury. J. Am. Soc. Nephrol. (2002) 13:350-358.
87. MCQUALTER JL, DARWICHE R, EWING C et al.: Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J. Exp. Med. (2001) 194:873-882.
88. CAMPBELL IK, O'DONNELL K, LAWLOR KE, WICKS IP: Severe inflammatory arthritis and lymphadenopathy in the absence of TNF. J. Clin. Invest. (2001) 107:1519-1527.
89. BERNARD F, THOMAS C, EMILE JF et al.: Transient hematologic and clinical effect of E21R in a child with end-stage juvenile myelomonocytic leukemia. Blood (2002) 99:2615-2616.
90. SUN Q, JONES K, MCCLURE B: Simultaneous antagonism of interleukin-5, granulocyte-macrophage colony-stimulating factor, and interleukin-3 stimulation of human eosinophils by targetting the common cytokine binding site of their receptors. Blood(1999) 94:1943-1951.
91. RAMSHAW HS, WOODCOCK JM, BAGLEY CJ, MCCLURE BJ, HERCUS TR, LOPEZ AF: New approaches in the treatment of asthma. Immunol. Cell Biol. (2001) 79:154-159.